Pub. Date : 2021
PMID : 33748144
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Although the use of the BCR-ABL tyrosine kinase inhibitors (TKIs), such as imatinib, nilotinib, dasatinib, bosutinib, and ponatinib have increased the overall survival of CML patients, their use is limited by drug resistance and severe adverse effects. | Dasatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |